Iran’s medical and pharmaceutical industry is one of the country’s most advanced and strategic sectors, encompassing the production of chemical, herbal, and biological medicines, medical equipment, and healthcare services. It plays a critical role in ensuring public health, job creation, and export development.

Iran has strong research and manufacturing infrastructure, a skilled scientific workforce, and numerous knowledge-based companies active in pharmaceuticals, biotechnology, and medical devices. The country has developed the capability to produce many complex and strategic drugs domestically, including biosimilars and advanced formulations.

This industry is a high-value sector that meets the majority of domestic demand, reduces reliance on imports, creates employment for specialists, and supports a broad supply chain. Investments in this sector typically offer high returns and long-term growth potential.

Iran supplies human pharmaceuticals, herbal medicines, serums, medical equipment, and active pharmaceutical ingredients (APIs) to countries in the Middle East, Central Asia, Africa, and parts of Europe. Competitive pricing, acceptable quality, and scalable production capacity have helped Iranian products succeed in these markets.

Iran’s competitive advantages include a highly educated workforce, extensive production infrastructure, access to nearby regional markets, and low manufacturing costs. Expanding international certifications, strengthening national branding, and promoting scientific cooperation can further enhance Iran’s global competitiveness in the medical and pharmaceutical sector.